Zielinska-Pukos MA, Wesoowska A, Hamulka J
A phase Ib study of linsitinib (OSI-906), a dual inhibitor of IGF-1R and IR tyrosine kinase, in combination with everolimus as treatment for patients with refractory metastatic colorectal cancer
GHK-Cu peptide has been researched for its potential across a variety of functions (1) including that it may tighten and reverse the thinning of aging skin structure, supporting the extracellular matrix, that it may restore the skin barrier and moderate texture, hyperpigmentation and lesions, may support tissue repair and mitigate inflammation, may stimulate increasing hair follicle size, may exert antioxidant properties and, finally, may exhibit gene restructuring potential.
Lee & staff
Trigonelline: Contributes to aroma and may have potential neuroprotective effects
(cymbiotika.com) What is the best time of day to take glutathione